drugset
Drugs / A10
last change May 2011 re-read 3 minutes ago

A10

also known as Atengenal
Developed for
brain cancer
Investigated by
Burzynski Research Institute

Trials 1

today NCT00003475 · Ph 2
19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00003475 Feb 1996 → May 2011 brain cancer Burzynski Research Institute Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as A10 “A10 (Atengenal); AS2-1 (Astugenal)” NCT00003475 ↗
Known as Atengenal “A10 (Atengenal); AS2-1 (Astugenal)” NCT00003475 ↗
Route Intravenous “by IV infusion” NCT00003475 ↗